1. THU0397 Increased Bone Mass and Bone Strength by Sclerostin Antibody (Scl-Ab) is Maintained by a RANKL Inhibitor in OVX Rats with Established Osteopenia. (23rd January 2014) Authors: Ominsky, M.; Li, X.; Warmington, K.; Niu, Q.-T.; Asuncion, F.; Dwyer, D.; Grisanti, M.; Han, C.-Y.; Kostenuik, P.; Stolina, M.; Ke, H. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗